Cargando…

Association of the C47T Polymorphism in SOD2 with Amnestic Mild Cognitive Impairment and Alzheimer's Disease in Carriers of the APOEε4 Allele

Oxidative stress plays an important part in amnestic mild cognitive impairment (aMCI), the prodromal phase of Alzheimer's disease (AD). Recent evidence shows that polymorphisms in the SOD2 gene affect the elimination of the reactive oxygen species (ROS) generated in mitochondria. The aim of thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gamarra, David, Elcoroaristizabal, Xabier, Fernández-Martínez, Manuel, de Pancorbo, Marian M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678069/ https://www.ncbi.nlm.nih.gov/pubmed/26696693 http://dx.doi.org/10.1155/2015/746329

Ejemplares similares

The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers
por: Martínez, Manuel Fernández, et al.
Publicado: (2009)

Oestrogen receptor polymorphisms are an associated risk factor for mild cognitive impairment and Alzheimer disease in women APOE ɛ4 carriers: a case–control study
por: Fernández-Martínez, Manuel, et al.
Publicado: (2013)

Identification of epigenome-wide DNA methylation differences between carriers of APOE ε4 and APOE ε2 alleles
por: Walker, Rosie M., et al.
Publicado: (2021)

Increased hippocampal activation in ApoE-4 carriers and non-carriers with amnestic mild cognitive impairment
por: Tran, Tammy T., et al.
Publicado: (2016)

APOE ε4, an Alzheimer’s disease susceptibility allele, and smoking cessation
por: Ashare, Rebecca L., et al.
Publicado: (2012)

Decreased plasma C‐reactive protein levels in APOE ε4 allele carriers
por: Martiskainen, Henna, et al.
Publicado: (2018)

Association of APOE Serum Levels and APOE ε2, ε3, and ε4 Alleles with Optic Neuritis
por: Momkute, Liucija, et al.
Publicado: (2022)

Association of Pancreatic Polypeptide with Mild Cognitive Impairment Varies by APOE ε4 Allele
por: Roberts, Rosebud O., et al.
Publicado: (2015)

A loss of function variant in CASP7 protects against Alzheimer’s disease in homozygous APOE ε4 allele carriers
por: Ayers, Kristin L., et al.
Publicado: (2016)

Bioenergetic and inflammatory systemic phenotypes in Alzheimer’s disease APOE ε4‐carriers
por: Wilkins, Heather M., et al.
Publicado: (2021)

Sociodemographic data and APOE-ε4 augmentation for MRI-based detection of amnestic mild cognitive impairment using deep learning systems
por: Pelka, Obioma, et al.
Publicado: (2020)

A Systems View of the Differences between APOE ε4 Carriers and Non-carriers in Alzheimer’s Disease
por: Jiang, Shan, et al.
Publicado: (2016)

The APOE ε4 Allele Affects Cognitive Functions Differently in Carriers of APP Mutations Compared to Carriers of PSEN1 Mutations in Autosomal-Dominant Alzheimer’s Disease
por: Almkvist, Ove, et al.
Publicado: (2021)

THE APOE-ε4 ALLELE AND AGE SYNERGISTICALLY DRIVE DISEASE PROGRESSION IN ALZHEIMER’S DISEASE
por: Kleineidam, Luca, et al.
Publicado: (2019)

Effects of APOE ε2 allele on basal forebrain functional connectivity in mild cognitive impairment
por: Liu, Xiaocao, et al.
Publicado: (2022)

Associations of the APOE ε2 and ε4 alleles and polygenic profiles comprising APOE-TOMM40-APOC1 variants with Alzheimer’s disease biomarkers
por: Kulminski, Alexander M., et al.
Publicado: (2022)

The Effect of Apolipoprotein E ε4 (APOE ε4) on Visuospatial Working Memory in Healthy Elderly and Amnestic Mild Cognitive Impairment Patients: An Event-Related Potentials Study
por: Gu, Li-Hua, et al.
Publicado: (2017)

Dissecting the Gene Dose-Effects of the APOE ε4 and ε2 Alleles on Hippocampal Volumes in Aging and Alzheimer’s Disease
por: Hostage, Christopher A., et al.
Publicado: (2013)

APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease
por: Hou, Min, et al.
Publicado: (2021)

Association analysis of polymorphisms in STARD6 and near ECHDC3 in Alzheimer’s disease patients carrying the APOE ε4 Allele
por: Yin, Jiajun, et al.
Publicado: (2019)

Anxiety correlates with cortical surface area in subjective cognitive decline: APOE ε4 carriers versus APOE ε4 non-carriers
por: Sun, Yu, et al.
Publicado: (2019)

Effect of APOE ε4 genotype on amyloid‐β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment
por: Li, Weihua, et al.
Publicado: (2022)

Platelet cytochrome oxidase and citrate synthase activities in APOE ε4 carrier and non-carrier Alzheimer's disease patients
por: Wilkins, Heather M., et al.
Publicado: (2017)

Sex and APOE: A memory advantage in male APOE ε4 carriers in midlife
por: Zokaei, Nahid, et al.
Publicado: (2017)

Common BACE2 Polymorphisms are Associated with Altered Risk for Alzheimer’s Disease and CSF Amyloid Biomarkers in APOE ε4 Non-Carriers
por: Huentelman, Matt, et al.
Publicado: (2019)

Association between the APOE ε4 Allele and Late-Onset Alzheimer's Disease in an Ecuadorian Mestizo Population
por: Montufar, Stefany, et al.
Publicado: (2017)

APOE ε4 Allele Is Associated with Elevated Levels of CSF VILIP-1 in Preclinical Alzheimer’s Disease
por: Wang, Lijun, et al.
Publicado: (2020)

Higher Brain Perfusion May Not Support Memory Functions in Cognitively Normal Carriers of the ApoE ε4 Allele Compared to Non-Carriers
por: Zlatar, Zvinka Z., et al.
Publicado: (2016)

Alterations in dorsal and ventral posterior cingulate connectivity in APOE ε4 carriers at risk of Alzheimer's disease
por: Kerestes, Rebecca, et al.
Publicado: (2015)

CDH6 and HAGH protein levels in plasma associate with Alzheimer’s disease in APOE ε4 carriers
por: Ahmad, Shahzad, et al.
Publicado: (2020)

Updated meta-analysis of the role of APOE ε2/ε3/ε4 alleles in frontotemporal lobar degeneration
por: Su, Wen-Hua, et al.
Publicado: (2017)

Effect of APOE ε4 allele on survival and fertility in an adverse environment
por: van Exel, Eric, et al.
Publicado: (2017)

Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele
por: Padayachee, E.R., et al.
Publicado: (2016)

Patients with Alzheimer's disease who carry the APOE ε4 allele benefit more from physical exercise
por: Jensen, Camilla Steen, et al.
Publicado: (2019)

Relationship between the Presence of the ApoE ε4 Allele and EEG Complexity along the Alzheimer’s Disease Continuum
por: Gutiérrez-de Pablo, Víctor, et al.
Publicado: (2020)

The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer’s Disease
por: Fan, Yulan, et al.
Publicado: (2021)

Association of CSF GAP-43 and APOE ε4 with Cognition in Mild Cognitive Impairment and Alzheimer’s Disease
por: Zhu, Yueli, et al.
Publicado: (2022)

The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers
por: Sánchez-Juan, Pascual, et al.
Publicado: (2019)

Novel Alzheimer’s disease risk variants identified based on whole-genome sequencing of APOE ε4 carriers
por: Park, Jong-Ho, et al.
Publicado: (2021)

Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers
por: Hackenhaar, Fernanda Schäfer, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cco3rvgetiu9mc271e4ot0tcrv